In-Vitro IBD Diagnostic Market Size

In-Vitro Inflammatory Bowel Disease (IBD) Diagnostic Market size was over USD 1.83 billion in 2023 and is projected to reach USD 3.58 billion by 2036, growing at around 5.3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of in-vitro IBD diagnostic is assessed at USD 1.91 billion.

The growth of the market can be primarily attributed to the growing prevalence of inflammatory bowel disease worldwide, and therefore the need amongst individuals to diagnose the disease. Moreover, the market is also anticipated to grow on account of the growing healthcare expenditure and the rising research activities in the field of gastro sciences.

The in-vitro inflammatory bowel disease (IBD) diagnostic market is also expected to grow on account of the growing concern for the increasing incidences of digestive diseases worldwide and the increasing awareness amongst individuals to treat such diseases. According to the statistics by the Institute for Health Metrics and Evaluation (IHME), deaths caused due to digestive diseases around the globe increased from 726331.36 deaths in the year 2000 to 939281 deaths in the year 2019.